跳转至内容
Merck
  • Molecular Mechanisms Underlying Urate-Induced Enhancement of Kv1.5 Channel Expression in HL-1 Atrial Myocytes.

Molecular Mechanisms Underlying Urate-Induced Enhancement of Kv1.5 Channel Expression in HL-1 Atrial Myocytes.

Circulation journal : official journal of the Japanese Circulation Society (2015-10-20)
Nani Maharani, Ya Kuang Ting, Jidong Cheng, Akira Hasegawa, Yasutaka Kurata, Peili Li, Yuji Nakayama, Haruaki Ninomiya, Nobuhito Ikeda, Kumi Morikawa, Kazuhiro Yamamoto, Naomasa Makita, Takeshi Yamashita, Yasuaki Shirayoshi, Ichiro Hisatome
摘要

Hyperuricemia induces endothelial dysfunction, oxidative stress and inflammation, increasing cardiovascular morbidities. It also raises the incidence of atrial fibrillation; however, underlying mechanisms are unknown. The effects of urate on expression of Kv1.5 in cultured mouse atrial myocytes (HL-1 cells) using reverse transcriptase-PCR, immunoblots, flow cytometry and patch-clamp experiments were studied. Treatment with urate at 7 mg/dl for 24 h increased the Kv1.5 protein level, enhanced ultra-rapid delayed-rectifier K(+)channel currents and shortened action potential duration in HL-1 cells. HL-1 cells expressed the influx uric acid transporter (UAT), URATv1, and the efflux UATs, ABCG2 and MRP4. An inhibitor against URATv1, benzbromarone, abolished the urate effects, whereas an inhibitor against ABCG2, KO143, augmented them. Flow cytometry showed that urate induced an increase in reactive oxygen species, which was abolished by the antioxidant, N-acetylcysteine (NAC), and the NADPH-oxidase inhibitor, apocynin. Both NAC and apocynin abolished the enhancing effects of urate on Kv1.5 expression. A urate-induced increase in the Kv1.5 proteins was accompanied by phosphorylation of extracellular signal-regulated kinase (ERK), and was abolished by an ERK inhibitor, PD98059. NAC abolished phosphorylation of ERK by urate. Intracellular urate taken up by UATs enhanced Kv1.5 protein expression and function in HL-1 atrial myocytes, which could be attributable to ERK phosphorylation and oxidative stress derived from nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase.

材料
货号
品牌
产品描述

Sigma-Aldrich
氢氧化钾, ACS reagent, ≥85%, pellets
Sigma-Aldrich
氢氧化钾, reagent grade, 90%, flakes
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, BioReagent, suitable for cell culture
Sigma-Aldrich
1mol 氢氧化钾浓缩液 溶液, 45 wt. % in H2O
Sigma-Aldrich
氢氧化钾, semiconductor grade, pellets, 99.99% trace metals basis (Purity excludes sodium content.)
Sigma-Aldrich
2',7'-二氯荧光素二乙酸酯, ≥97%
Supelco
1mol 氢氧化钾浓缩液 溶液, volumetric, 8.0 M KOH (8.0N)
Sigma-Aldrich
氢氧化钾, ≥85% KOH basis, pellets, white
Sigma-Aldrich
氢氧化钾, BioXtra, ≥85% KOH basis
Sigma-Aldrich
氢氧化钾, technical, ≥85%, powder
Sigma-Aldrich
氢氧化钾, puriss., meets analytical specification of Ph. Eur., BP, 85-100.5%, pellets
Sigma-Aldrich
氢氧化钾, pellets, reag. Ph. Eur., ≥85%
Sigma-Aldrich
氢氧化钾, anhydrous, ≥99.95% trace metals basis
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, Sigma Grade, ≥99% (TLC), powder
Sigma-Aldrich
尿酸 钠盐
Sigma-Aldrich
氢氧化钾, puriss. p.a., ≥86% (T), pellets
Sigma-Aldrich
4′-羟基-3′-甲氧基苯乙酮, 98%
Sigma-Aldrich
香草乙酮, ≥98%, FG
Sigma-Aldrich
1mol 氢氧化钾浓缩液 溶液, 0.5 M in ethanol
Sigma-Aldrich
1mol 氢氧化钾浓缩液 溶液, 1 M
Sigma-Aldrich
1mol 氢氧化钾浓缩液 溶液, 0.1 M
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, BioXtra, ≥99% (TLC)
Sigma-Aldrich
1mol 氢氧化钾浓缩液 溶液, 0.1 M in ethanol
Sigma-Aldrich
1mol 氢氧化钾浓缩液 溶液, 0.5 M
Sigma-Aldrich
1mol 氢氧化钾浓缩液 溶液, 0.1 M in isopropanol
Sigma-Aldrich
1mol 氢氧化钾浓缩液 溶液, 0.02 M in ethanol
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, SAJ special grade, 98.0-102.0%
Sigma-Aldrich
氢氧化钾, free-flowing, Redi-Dri, ACS reagent, ≥85%, pellets
Sigma-Aldrich
Amyloid Protein Non-Aβ Component, ≥80% (HPLC)